Stock Events

Stock Events

NFL Biosciences. 

€0.95
17
+€0.01+0.53% Today

Statistics

Day High
0.95
Day Low
0.95
52W High
1.72
52W Low
0.79
Volume
0
Avg. Volume
-
Mkt Cap
12.06M
P/E Ratio
-
Dividend Yield
-
Dividend
-

Earnings

15AprExpected
Q2 2024
Q1 2025
Q3 2025
Q1 2026
999
333
-333
-999
Expected EPS
N/A
Actual EPS
N/A

Financials

-Profit Margin
Unprofitable
2019
2020
2021
2022
2023
2024
0Revenue
-4.89MNet Income

People Also Follow

This list is based on the watchlists of people on Stock Events who follow 82F.F. It's not an investment recommendation.
Alphabet
79493
GOOGL
Apple
69146
AAPL
Microsoft
64576
MSFT
Amazon
60260
AMZN

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Corbus Pharmaceuticals
CRBP
Mkt Cap178.43M
Corbus Pharmaceuticals Holdings, Inc. is involved in the development of drugs to treat inflammatory and fibrotic diseases, a similar therapeutic area to some of NFL Biosciences' targets.
Aurora Cannabis
ACB
Mkt Cap200.44M
Aurora Cannabis Inc. is a Canadian licensed cannabis producer, involved in the medical cannabis market which overlaps with NFL Biosciences' focus on therapeutic products derived from natural substances.
Canopy Growth
CGC
Mkt Cap501.04M
Canopy Growth Corporation is a world-leading diversified cannabis and cannabinoid-based medicines company, directly competing in the same industry as NFL Biosciences.
Tilray Brands
TLRY
Mkt Cap807.33M
Tilray, Inc. engages in the research, cultivation, production, and distribution of medical cannabis and cannabinoids, which puts it in direct competition with NFL Biosciences' therapeutic product development.
Cronos Group
CRON
Mkt Cap1.02B
Cronos Group Inc. is an innovative global cannabinoid company, with international production and distribution across five continents, competing in the cannabinoid product market.

About

NFL Biosciences SA, a biotechnology company, engages in the development of botanical drugs in France. The company's pipeline includes NFL-101, a drug candidate for smoking cessation, currently under Phase 2b clinical trials; and NFL-301, a drug candidate for reducing alcohol consumption which is in preclinical stage. It has scientific collaboration with McLean Hospital to deepen the understanding of the mechanism of action of NFL-101, its proprietary botanical drug candidate for smoking cessation. NFL Biosciences SA was incorporated in 2006 and is headquartered in Castelnau-le-Lez, France.
Show more...
CEO
Mr. Bruno Lafont M.B.A., M.Sc.
Employees
5
Country
France
ISIN
FR0014003XT0
WKN
000A3CTQ0

Listings

STU
DE
82F.STU
F
DE
82F.F
PA
FR
ALNFL.PA

0 Comments

Share your thoughts

FAQ

What is NFL Biosciences. stock price today?▼
The current price of 82F.F is €0.95 EUR — it has increased by +0.53% in the past 24 hours. Watch NFL Biosciences. stock price performance more closely on the chart.
What is NFL Biosciences. stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on exchange NFL Biosciences. stocks are traded under the ticker 82F.F.
Is NFL Biosciences. stock price growing?▼
82F.F stock has fallen by -1.55% compared to the previous week, the month change is a -7.93% fall, over the last year NFL Biosciences. has showed a -33.43% decrease.
What is NFL Biosciences. market cap?▼
Today NFL Biosciences. has the market capitalization of 12.06M
What is NFL Biosciences. revenue for the last year?▼
NFL Biosciences. revenue for the last year amounts to 0 EUR.
What is NFL Biosciences. net income for the last year?▼
82F.F net income for the last year is -4.89M EUR.
How many employees does NFL Biosciences. have?▼
As of April 29, 2026, the company has 5 employees.
In which sector is NFL Biosciences. located?▼
NFL Biosciences. operates in the Health & Wellness sector.
When did NFL Biosciences. complete a stock split?▼
NFL Biosciences. has not had any recent stock splits.
Where is NFL Biosciences. headquartered?▼
NFL Biosciences. is headquartered in Castelnau-le-Lez, France.